Sinan Guloksuz
Sinan Guloksuz
Associate Professor at Maastricht University
Verified email at yale.edu
Title
Cited by
Cited by
Year
Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression
CU Correll, B Galling, A Pawar, A Krivko, C Bonetto, M Ruggeri, TJ Craig, ...
JAMA psychiatry 75 (6), 555-565, 2018
3232018
The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
S Guloksuz, J van Os
Psychological medicine 48 (2), 229-244, 2018
2112018
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia Bulletin 40 (4), 729-736, 2014
2052014
A critique of the “ultra‐high risk” and “transition” paradigm
J van Os, S Guloksuz
World Psychiatry 16 (2), 200-206, 2017
1932017
Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
C Tek, S Kucukgoncu, S Guloksuz, SW Woods, VH Srihari, A Annamalai
Focus 14 (3), 370-377, 2016
1472016
A network approach to environmental impact in psychotic disorder: brief theoretical framework
AM Isvoranu, D Borsboom, J van Os, S Guloksuz
Schizophrenia Bulletin 42 (4), 870-873, 2016
1382016
Application of network methods for understanding mental disorders: pitfalls and promise
S Guloksuz, LK Pries, J Van Os
Psychological medicine 47 (16), 2743-2752, 2017
1182017
The experience sampling method as an mHealth tool to support self‐monitoring, self‐insight, and personalized health care in clinical practice
J van Os, S Verhagen, A Marsman, F Peeters, M Bak, M Marcelis, ...
Depression and anxiety 34 (6), 481-493, 2017
1072017
Cytokine levels in euthymic bipolar patients
S Guloksuz, EA Cetin, T Cetin, G Deniz, ET Oral, DJ Nutt
Journal of affective disorders 126 (3), 458-462, 2010
1052010
The evidence‐based group‐level symptom‐reduction model as the organizing principle for mental health care: time for change?
J van Os, S Guloksuz, TW Vijn, A Hafkenscheid, P Delespaul
World Psychiatry 18 (1), 88-96, 2019
1042019
Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology
S Guloksuz, M van Nierop, R Lieb, R van Winkel, HU Wittchen, J van Os
Psychological medicine 45 (11), 2389-2401, 2015
812015
Images of psychiatry and psychiatrists
H Stuart, N Sartorius, T Liinamaa, Images Study Group
Acta Psychiatrica Scandinavica 131 (1), 21-28, 2015
762015
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
S Guloksuz, LK Pries, P Delespaul, G Kenis, JJ Luykx, BD Lin, ...
World Psychiatry 18 (2), 173-182, 2019
692019
Evidence for an association between tumor necrosis factor-alpha levels and lithium response
S Guloksuz, K Altinbas, EA Cetin, G Kenis, SB Gazioglu, G Deniz, ET Oral, ...
Journal of affective disorders 143 (1-3), 148-152, 2012
642012
The immune system and electroconvulsive therapy for depression
S Guloksuz, BPF Rutten, B Arts, J van Os, G Kenis
The journal of ECT 30 (2), 132-137, 2014
632014
Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience
J van Os, Y Van Der Steen, MA Islam, S Gülöksüz, BP Rutten, CJ Simons, ...
Psychological Medicine 47 (14), 2421-2437, 2017
572017
The link between the immune system, environment, and psychosis
R Radhakrishnan, M Kaser, S Guloksuz
Schizophrenia bulletin 43 (4), 693-697, 2017
532017
Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability
S Guloksuz, M Wichers, G Kenis, MGVM Russel, A Wauters, R Verkerk, ...
PLoS One 8 (3), e60435, 2013
522013
The impact of electroconvulsive therapy on the tryptophan–kynurenine metabolic pathway
S Guloksuz, B Arts, S Walter, M Drukker, L Rodriguez, AM Myint, ...
Brain, behavior, and immunity 48, 48-52, 2015
482015
The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial
C Tek, LB Palmese, AD Krystal, VH Srihari, PC DeGeorge, ...
Schizophrenia research 160 (1-3), 180-185, 2014
482014
The system can't perform the operation now. Try again later.
Articles 1–20